Crossmark

YCharOS protocol for antibody validation

Crossref DOI link: https://doi.org/10.1038/s41596-024-01108-6

Published Online: 2024-12-17

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Monteiro, Fátima L.

Voskuil, Jan L. A. https://orcid.org/0000-0003-0799-0548
Williams, Cecilia https://orcid.org/0000-0002-0602-2062
License Information

Text and Data Mining valid from 2024-12-17

Version of Record valid from 2024-12-17
More Information

Article History

First Online: 17 December 2024

Competing interests

: J.L.A.V. is CEO of the company Aeonian Biotech. F.L.M. and C.W. declare no competing interests.